Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1948 1
1949 1
1972 1
1974 1
1977 2
1978 3
1979 2
1980 1
1981 3
1983 3
1985 5
1986 6
1987 9
1988 8
1989 6
1991 3
1992 7
1993 7
1994 8
1995 4
1996 6
1997 3
1998 3
1999 1
2000 1
2001 1
2002 2
2003 3
2004 2
2005 6
2006 3
2007 3
2008 12
2009 4
2010 1
2011 4
2012 5
2013 7
2014 4
2015 9
2016 8
2017 7
2018 7
2019 6
2020 8
2021 8
2022 8
2023 7
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

207 results

Results by year

Filters applied: . Clear all
Page 1
Antibody-drug conjugates come of age in oncology.
Dumontet C, Reichert JM, Senter PD, Lambert JM, Beck A. Dumontet C, et al. Among authors: lambert jm. Nat Rev Drug Discov. 2023 Aug;22(8):641-661. doi: 10.1038/s41573-023-00709-2. Epub 2023 Jun 12. Nat Rev Drug Discov. 2023. PMID: 37308581 Review.
Diet, nutrients and the microbiome.
Dahl WJ, Rivero Mendoza D, Lambert JM. Dahl WJ, et al. Among authors: lambert jm. Prog Mol Biol Transl Sci. 2020;171:237-263. doi: 10.1016/bs.pmbts.2020.04.006. Epub 2020 Apr 25. Prog Mol Biol Transl Sci. 2020. PMID: 32475524 Review.
IMGN853, a Folate Receptor-α (FRα)-Targeting Antibody-Drug Conjugate, Exhibits Potent Targeted Antitumor Activity against FRα-Expressing Tumors.
Ab O, Whiteman KR, Bartle LM, Sun X, Singh R, Tavares D, LaBelle A, Payne G, Lutz RJ, Pinkas J, Goldmacher VS, Chittenden T, Lambert JM. Ab O, et al. Among authors: lambert jm. Mol Cancer Ther. 2015 Jul;14(7):1605-13. doi: 10.1158/1535-7163.MCT-14-1095. Epub 2015 Apr 22. Mol Cancer Ther. 2015. PMID: 25904506
Targeting HER2-positive breast cancer with trastuzumab-DM1, an antibody-cytotoxic drug conjugate.
Lewis Phillips GD, Li G, Dugger DL, Crocker LM, Parsons KL, Mai E, Blättler WA, Lambert JM, Chari RV, Lutz RJ, Wong WL, Jacobson FS, Koeppen H, Schwall RH, Kenkare-Mitra SR, Spencer SD, Sliwkowski MX. Lewis Phillips GD, et al. Among authors: lambert jm. Cancer Res. 2008 Nov 15;68(22):9280-90. doi: 10.1158/0008-5472.CAN-08-1776. Cancer Res. 2008. PMID: 19010901
Relapse and its mitigation: Toward behavioral inoculation.
Kimball RT, Greer BD, Fuhrman AM, Lambert JM. Kimball RT, et al. Among authors: lambert jm. J Appl Behav Anal. 2023 Apr;56(2):282-301. doi: 10.1002/jaba.971. Epub 2023 Jan 30. J Appl Behav Anal. 2023. PMID: 36715533 Free PMC article. Review.
Antibody-Drug Conjugates for Cancer Treatment.
Lambert JM, Berkenblit A. Lambert JM, et al. Annu Rev Med. 2018 Jan 29;69:191-207. doi: 10.1146/annurev-med-061516-121357. Annu Rev Med. 2018. PMID: 29414262 Review.
ADME of antibody-maytansinoid conjugates.
Erickson HK, Lambert JM. Erickson HK, et al. Among authors: lambert jm. AAPS J. 2012 Dec;14(4):799-805. doi: 10.1208/s12248-012-9386-x. Epub 2012 Aug 9. AAPS J. 2012. PMID: 22875610 Free PMC article. Review.
207 results